19-40597342-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The ENST00000308370.11(LTBP4):c.108G>A(p.Gln36=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00118 in 1,523,558 control chromosomes in the GnomAD database, including 27 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0056 ( 9 hom., cov: 30)
Exomes 𝑓: 0.00070 ( 18 hom. )
Consequence
LTBP4
ENST00000308370.11 synonymous
ENST00000308370.11 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.685
Genes affected
LTBP4 (HGNC:6717): (latent transforming growth factor beta binding protein 4) The protein encoded by this gene binds transforming growth factor beta (TGFB) as it is secreted and targeted to the extracellular matrix. TGFB is biologically latent after secretion and insertion into the extracellular matrix, and sheds TGFB and other proteins upon activation. Defects in this gene may be a cause of cutis laxa and severe pulmonary, gastrointestinal, and urinary abnormalities. Three transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, May 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.67).
BP6
Variant 19-40597342-G-A is Benign according to our data. Variant chr19-40597342-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 666629.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.685 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00558 (849/152244) while in subpopulation AFR AF= 0.0194 (804/41550). AF 95% confidence interval is 0.0182. There are 9 homozygotes in gnomad4. There are 405 alleles in male gnomad4 subpopulation. Median coverage is 30. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 9 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LTBP4 | NM_001042544.1 | c.108G>A | p.Gln36= | synonymous_variant | 1/33 | ||
LTBP4 | NM_003573.2 | c.17-1855G>A | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LTBP4 | ENST00000308370.11 | c.108G>A | p.Gln36= | synonymous_variant | 1/33 | 1 | A2 | ||
LTBP4 | ENST00000204005.13 | c.17-1855G>A | intron_variant | 1 | A2 | ||||
LTBP4 | ENST00000599016.5 | c.17-1855G>A | intron_variant, NMD_transcript_variant | 3 | |||||
LTBP4 | ENST00000600026.5 | c.17-1855G>A | intron_variant, NMD_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.00553 AC: 842AN: 152126Hom.: 9 Cov.: 30
GnomAD3 genomes
AF:
AC:
842
AN:
152126
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000867 AC: 104AN: 119928Hom.: 3 AF XY: 0.000697 AC XY: 46AN XY: 66044
GnomAD3 exomes
AF:
AC:
104
AN:
119928
Hom.:
AF XY:
AC XY:
46
AN XY:
66044
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000696 AC: 955AN: 1371314Hom.: 18 Cov.: 33 AF XY: 0.000672 AC XY: 455AN XY: 676724
GnomAD4 exome
AF:
AC:
955
AN:
1371314
Hom.:
Cov.:
33
AF XY:
AC XY:
455
AN XY:
676724
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00558 AC: 849AN: 152244Hom.: 9 Cov.: 30 AF XY: 0.00544 AC XY: 405AN XY: 74434
GnomAD4 genome
AF:
AC:
849
AN:
152244
Hom.:
Cov.:
30
AF XY:
AC XY:
405
AN XY:
74434
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
10
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 03, 2018 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Dec 31, 2018 | The p.Gln36Gln variant in LTBP4 is classified as benign because it has been iden tified in 1.8% (223/12680) of African chromosomes including 4 homozygotes by gno mAD (http://gnomad.broadinstitute.org). ACMG/AMP criteria applied: BA1. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at